CoChat

Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists

Open access

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

The underlying circuit imbalance in major depression remains unknown and current therapies remain inadequate for a large group of patients. Discovery of the rapid antidepressant effects of ketamine--an NMDA receptor (NMDAR) antagonist--has linked the glutamatergic system to depression. Interestingly, dysfunction in the inhibitory GABAergic system has also been proposed to underlie depression and deficits linked to GABAergic neurons have been found with human imaging and in post-mortem material from depressed patients. Parvalbumin-expressing (PV) GABAergic interneurons regulate local circuit function through perisomatic inhibition and their activity is NMDAR-dependent, providing a possible link between NMDAR and the inhibitory system in the antidepressant effect of ketamine. We have therefore investigated the role of the NMDAR-dependent activity of PV interneurons for the development of depression-like behavior as well as for the response to rapid antidepressant effects of NMDAR antagonists. We used mutant mice lacking NMDA neurotransmission specifically in PV neurons (PV-Cre+/NR1f/f) and analyzed depression-like behavior and anhedonia. To study the acute and sustained effects of a single NMDAR antagonist administration, we established a behavioral paradigm of repeated exposure to forced swimming test (FST). We did not observe altered behavioral responses in the repeated FST or in a sucrose preference test in mutant mice. In addition, the behavioral response to administration of NMDAR antagonists was not significantly altered in mutant PV-Cre+/NR1f/f mice. Our results show that NMDA-dependent neurotransmission in PV neurons is not necessary to regulate depression-like behaviors, and in addition that NMDARs on PV neurons are not a direct target for the NMDAR-induced antidepressant effects of ketamine and MK801.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0083879

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mice display stable behavior in a repeated FST paradigm. (A) Outline of the repeated FST protocol performed over several days. C57BL/6N mice (n = 12) were injected at time 0 with saline (arrow) and every mouse was subjected to FST 30 min, 24 h, 48 h, 72 h and 96 h later. After 4 days of rest in their home cages mice were retested in the FST once again (i.e. 240 h after saline injection). (B) Results (sec/4 min) are presented as mean values ±SEM. Immobility time is stable after repeated FST: 161±15 (30 min); 173±17 (24 h); 199±12 (48 h); 208±9 (72 h); 186±9 (96 h) and 183±9 (240 h) (p>0.05, one way ANOVA).
Figure 1 Mice display stable behavior in a repeated FST paradigm. (A) Outline of the repeated FST protocol performed over several days. C57BL/6N mice (n = 12) were injected at time 0 with saline (arrow) and every mouse was subjected to FST 30 min, 24 h, 48 h, 72 h and 96 h later. After 4 days of rest in their home cages mice were retested in the FST once again (i.e. 240 h after saline injection). (B) Results (sec/4 min) are presented as mean values ±SEM. Immobility time is stable after repeated FST: 161±15 (30 min); 173±17 (24 h); 199±12 (48 h); 208±9 (72 h); 186±9 (96 h) and 183±9 (240 h) (p>0.05, one way ANOVA).CC BY · PubMed Central
Figure 2 Loss of NMDAR in PV neurons does not affect behavior in the repeated FST paradigm. Immobility of mice lacking NMDAR specifically in PV interneurons (PV-Cre+/NR1f/f,red bars) and control mice (NR1f/f, black bars) during repeated FST. (A) Outline of the repeated FST protocol performed over several days. PV-Cre+/NR1f/f and NR1f/f mice were injected at time 0 with saline (arrow) and every mouse was subjected to FST 30 min, 24 h, 48 h, 72 h and 96 h later. After 4 days of rest in their home cages mice were retested in the FST once again (i.e. 240 h after saline injection). (B) Immobility time is stable after repeated FST in both genotypes. Results (sec/4 min) are presented as mean values ±SEM. Immobility time for NR1f/f mice (black bars, n = 10) is:185±5 (30 min), 205±6 (24 h), 209±8 (48 h), 214±5 (72 h), 187±13 (96 h) and 174±16 (240 h). Immobility time for PV-Cre+/NR1f/f mice (red bars, n = 10) is: 186±5 (30 min), 203±7 (24 h), 207±6 (48 h), 208±4 (72 h), 191±10 (96 h) and 175±7 (240 h).
Figure 2 Loss of NMDAR in PV neurons does not affect behavior in the repeated FST paradigm. Immobility of mice lacking NMDAR specifically in PV interneurons (PV-Cre+/NR1f/f,red bars) and control mice (NR1f/f, black bars) during repeated FST. (A) Outline of the repeated FST protocol performed over several days. PV-Cre+/NR1f/f and NR1f/f mice were injected at time 0 with saline (arrow) and every mouse was subjected to FST 30 min, 24 h, 48 h, 72 h and 96 h later. After 4 days of rest in their home cages mice were retested in the FST once again (i.e. 240 h after saline injection). (B) Immobility time is stable after repeated FST in both genotypes. Results (sec/4 min) are presented as mean values ±SEM. Immobility time for NR1f/f mice (black bars, n = 10) is:185±5 (30 min), 205±6 (24 h), 209±8 (48 h), 214±5 (72 h), 187±13 (96 h) and 174±16 (240 h). Immobility time for PV-Cre+/NR1f/f mice (red bars, n = 10) is: 186±5 (30 min), 203±7 (24 h), 207±6 (48 h), 208±4 (72 h), 191±10 (96 h) and 175±7 (240 h).CC BY · PubMed Central
Figure 3 Ketamine and MK801 do not affect locomotor activity behavior in the open field. Time course for the locomotor activity of C57BL/6N mice in the 60 min before and 60 min after saline (black circles, n = 5), ketamine (gray circles, n = 6) and MK801 (white circles, n = 5) injection (arrow) (p>0.05, one way ANOVA).
Figure 3 Ketamine and MK801 do not affect locomotor activity behavior in the open field. Time course for the locomotor activity of C57BL/6N mice in the 60 min before and 60 min after saline (black circles, n = 5), ketamine (gray circles, n = 6) and MK801 (white circles, n = 5) injection (arrow) (p>0.05, one way ANOVA).CC BY · PubMed Central
Figure 4 Ketamine-induced antidepressant-like behavioral effects in the FST. Ketamine-induced immobility and swimming time, respectively, in C57BL/6N mice (A,B) and in mice lacking NMDAR specifically in PV neurons (PV-Cre+/NR1f/f, red bars) compared with control (NR1f/f, black bars)(C,D). (A) Immobility of C57BL/6N mice in repeated FST 30 min, 24 h and 1 week after acute treatment with 3.0 mg/kg ketamine (grey bars, n = 8) or saline (black bars, n = 8). Results (sec/4 min) are presented as mean values ±SEM. Ketamine induces a rapid antidepressant response by significantly reducing immobility already 30 min after treatment. The antidepressant effect decreases over time. Ketamine-induced immobility time is: 192±5 saline and 116±16 ketamine (30 min) (p<0.001 Student's t-test); 196±8 saline and 149±17 ketamine (24 h) (p<0.05 Student's t-test); 183±14 saline and 163±14 ketamine (1 week) (p>0.05 Student's t-test). (B) Swimming scored in the experiment in (A). Ketamine-induced swimming time is: 47±5 saline and 123±16 ketamine (30 min) (p<0.001 Student's t-test); 44±8 saline and 91±17 ketamine (24 h) (p<0.05 Student's t-test); 57±14 saline and 77±14 ketamine (1 week) (p>0.05 Student's t-test). (C) Immobility of PV-Cre+/NR1f/f and NR1f/f mice in repeated FST after acute treatment with 3.0 mg/kg ketamine. Immobility time 30 min, 24 h and 1 week after ketamine is: 89±15, 121±13 and 174±11 (NR1f/f black bars, n = 6); 84±19, 83±14 and 155±12 (PV-Cre+/NR1f/f red bars, n = 9), respectively. (D) Swimming scored in the experiment in (C). Swimming time 30 min, 24 h and 1 week after ketamine is: 145±14, 118±13 and 66±11 (NR1f/f black bars, n = 6); 149±18, 156±14 and 85±12 (PV-Cre+/NR1f/red bars, n = 9), respectively. Both genotypes display similar behavioral response to the ketamine treatment. Results (sec/4 min) are presented as mean values ±SEM.
Figure 4 Ketamine-induced antidepressant-like behavioral effects in the FST. Ketamine-induced immobility and swimming time, respectively, in C57BL/6N mice (A,B) and in mice lacking NMDAR specifically in PV neurons (PV-Cre+/NR1f/f, red bars) compared with control (NR1f/f, black bars)(C,D). (A) Immobility of C57BL/6N mice in repeated FST 30 min, 24 h and 1 week after acute treatment with 3.0 mg/kg ketamine (grey bars, n = 8) or saline (black bars, n = 8). Results (sec/4 min) are presented as mean values ±SEM. Ketamine induces a rapid antidepressant response by significantly reducing immobility already 30 min after treatment. The antidepressant effect decreases over time. Ketamine-induced immobility time is: 192±5 saline and 116±16 ketamine (30 min) (p<0.001 Student's t-test); 196±8 saline and 149±17 ketamine (24 h) (p<0.05 Student's t-test); 183±14 saline and 163±14 ketamine (1 week) (p>0.05 Student's t-test). (B) Swimming scored in the experiment in (A). Ketamine-induced swimming time is: 47±5 saline and 123±16 ketamine (30 min) (p<0.001 Student's t-test); 44±8 saline and 91±17 ketamine (24 h) (p<0.05 Student's t-test); 57±14 saline and 77±14 ketamine (1 week) (p>0.05 Student's t-test). (C) Immobility of PV-Cre+/NR1f/f and NR1f/f mice in repeated FST after acute treatment with 3.0 mg/kg ketamine. Immobility time 30 min, 24 h and 1 week after ketamine is: 89±15, 121±13 and 174±11 (NR1f/f black bars, n = 6); 84±19, 83±14 and 155±12 (PV-Cre+/NR1f/f red bars, n = 9), respectively. (D) Swimming scored in the experiment in (C). Swimming time 30 min, 24 h and 1 week after ketamine is: 145±14, 118±13 and 66±11 (NR1f/f black bars, n = 6); 149±18, 156±14 and 85±12 (PV-Cre+/NR1f/red bars, n = 9), respectively. Both genotypes display similar behavioral response to the ketamine treatment. Results (sec/4 min) are presented as mean values ±SEM.CC BY · PubMed Central
Figure 5 MK801-induced antidepressant-like behavioral effects in the FST. MK801-induced immobility and swimming time in C57BL/6N mice (A,B) and in mice lacking NMDAR specifically in PV neurons (PV-Cre+/NR1f/f, red bars) compared with control (NR1f/f, black bars) (C,D). (A) Immobility of C57BL/6N mice in repeated FST 30 min, 24 h and 1 week after acute treatment with 0.1 mg/kg MK801 (white bars, n = 10) or water (black bars, n = 10). MK801 induces rapid antidepressant-like responses to a lesser extent than ketamine 30 min after treatment. The antidepressant effect of MK801 is abolished 24 h and 1 week after treatment. MK801-induced immobility time is: 220±3 water and 171±17 MK801 (30 min) (p<0.05 Student's t-test); 224±5 water and 223±3 MK801 (24 h) (p>0.05 Student's t-test); 197±10 water and 215±7 MK801 (1 week) (p>0.05 Student's t-test). (B) Swimming scored in the experiment in (A). MK801-induced swimming time is: 20±3 water and 68±17 MK801 (30 min) (p<0.05 Student's t-test); 15±4 water and 16±3 MK801 (24 h) (p>0.05 Student's t-test); 42±10 water and 24±7 MK801 (1week) (p>0.05 Student's t-test). (C) Immobility of PV-Cre+/NR1f/f (red bars) and NR1f/f (black bars) mice in repeated FST 30 min and 24 h after acute treatment with 0.1 mg/kg MK801. Immobility time 30 min and 24 h after MK801 is: 65±16 and 104±13 (NR1f/f black bars, n = 13); 54±16 and 103±16 (PV-Cre+/NR1f/f red bars, n = 14), respectively. (D) Swimming scored in the experiment in (C). Swimming time 30 min and 24 h after MK801 is: 168±15 and 135±16 (NR1f/f black bars, n = 13); 183±15 and 130±14 (PV-Cre+/NR1f/f red bars, n = 14), respectively. All time points p>0,05 (Student's t-test). Both genotypes display similar behavioral response to the MK801 treatment. Results (sec/4 min) are presented as mean values ±SEM.
Figure 5 MK801-induced antidepressant-like behavioral effects in the FST. MK801-induced immobility and swimming time in C57BL/6N mice (A,B) and in mice lacking NMDAR specifically in PV neurons (PV-Cre+/NR1f/f, red bars) compared with control (NR1f/f, black bars) (C,D). (A) Immobility of C57BL/6N mice in repeated FST 30 min, 24 h and 1 week after acute treatment with 0.1 mg/kg MK801 (white bars, n = 10) or water (black bars, n = 10). MK801 induces rapid antidepressant-like responses to a lesser extent than ketamine 30 min after treatment. The antidepressant effect of MK801 is abolished 24 h and 1 week after treatment. MK801-induced immobility time is: 220±3 water and 171±17 MK801 (30 min) (p<0.05 Student's t-test); 224±5 water and 223±3 MK801 (24 h) (p>0.05 Student's t-test); 197±10 water and 215±7 MK801 (1 week) (p>0.05 Student's t-test). (B) Swimming scored in the experiment in (A). MK801-induced swimming time is: 20±3 water and 68±17 MK801 (30 min) (p<0.05 Student's t-test); 15±4 water and 16±3 MK801 (24 h) (p>0.05 Student's t-test); 42±10 water and 24±7 MK801 (1week) (p>0.05 Student's t-test). (C) Immobility of PV-Cre+/NR1f/f (red bars) and NR1f/f (black bars) mice in repeated FST 30 min and 24 h after acute treatment with 0.1 mg/kg MK801. Immobility time 30 min and 24 h after MK801 is: 65±16 and 104±13 (NR1f/f black bars, n = 13); 54±16 and 103±16 (PV-Cre+/NR1f/f red bars, n = 14), respectively. (D) Swimming scored in the experiment in (C). Swimming time 30 min and 24 h after MK801 is: 168±15 and 135±16 (NR1f/f black bars, n = 13); 183±15 and 130±14 (PV-Cre+/NR1f/f red bars, n = 14), respectively. All time points p>0,05 (Student's t-test). Both genotypes display similar behavioral response to the MK801 treatment. Results (sec/4 min) are presented as mean values ±SEM.CC BY · PubMed Central
Figure 6 Sucrose preference test in animals lacking NMDAR in PV neurons. (A) Outline of the water intake and the sucrose preference test in PV-Cre+/NR1f/f and NR1f/f mice. (B) Water intake test (WIT) in mice lacking NMDAR specifically in PV neurons (PV-Cre+/NR1f/f, red bars, n = 9) compared with control mice (NR1f/f, black bars, n = 6). WIT was run for 24 h. Results (gr) are presented as mean values ±SEM (p>0,05;Student's t-test). (C) Sucrose preference test (SPT) in mice lacking NMDAR specifically in PV neurons (PV-Cre+/NR1f/f, red bars, n = 9) compared with control mice (NR1f/f, black bars, n = 6). SPT was run for 72 h. Results (sucrose intake/total intake ×100) are presented as mean values ±SEM (p>0,05;Student's t-test). Both genotypes display similar behavioral response.
Figure 6 Sucrose preference test in animals lacking NMDAR in PV neurons. (A) Outline of the water intake and the sucrose preference test in PV-Cre+/NR1f/f and NR1f/f mice. (B) Water intake test (WIT) in mice lacking NMDAR specifically in PV neurons (PV-Cre+/NR1f/f, red bars, n = 9) compared with control mice (NR1f/f, black bars, n = 6). WIT was run for 24 h. Results (gr) are presented as mean values ±SEM (p>0,05;Student's t-test). (C) Sucrose preference test (SPT) in mice lacking NMDAR specifically in PV neurons (PV-Cre+/NR1f/f, red bars, n = 9) compared with control mice (NR1f/f, black bars, n = 6). SPT was run for 72 h. Results (sucrose intake/total intake ×100) are presented as mean values ±SEM (p>0,05;Student's t-test). Both genotypes display similar behavioral response.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

See all 74

Metadata

Authors
Pozzi, L., Dorocic, I. P., Wang, X., Carlén, M., & Meletis, K.
Affiliations
Karolinska Institutet (SE)
Corresponding author
Meletis, Konstantinos
Venue
PLoS ONE
Published
2014-01-16
Volume
9
Issue
1
Pages
e83879
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2143999471
Cited by
74
References
49
Citations by year
2026: 2 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 6 · 2020: 8 · 2019: 12 · 2018: 8 · 2017: 4 · 2016: 5 · 2015: 12 · 2014: 5
FWCI
6.32
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Alliance for Research on Schizophrenia and Depression
  • Karolinska Institutet
  • Vetenskapsrådet
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
NMDA receptor, parvalbumin interneurons, depression-like behavior, anhedonia, ketamine, rapid antidepressant effects, NMDA receptor antagonists, MK-801, GABAergic inhibition, glutamatergic system, forced swim test, sucrose preference
MeSH terms
Animals, Antidepressive Agents, Major Depressive Disorder, Depressive Disorder, Major, Disease Models, Animal, Food Preferences, Humans, Interneurons, Ketamine, Male, Mice, Inbred C57BL, Mice, Transgenic, Motor Activity, Parvalbumins, Swimming, Receptors, N-Methyl-D-Aspartate, Dizocilpine Maleate, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists. https://app.cochat.ai/papers/10.1371/journal.pone.0083879
The paper
Pozzi, L., Dorocic, I. P., Wang, X., Carlén, M., & Meletis, K. (2014). Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists. PLoS ONE. https://doi.org/10.1371/journal.pone.0083879

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.